Data

Click on Protocol Number of interest to view study-related documentation or download data files. (DTMC data files are under development.)
Division Sort ascending Study Number Title Investigator(s) Release Date
CTN NIDA-CTN-0001 Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification Walter Ling, M.D. May 08, 2006
CTN NIDA-CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification Walter Ling, M.D. Jul 26, 2006
CTN NIDA-CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules Walter Ling, M.D. May 29, 2008
CTN NIDA-CTN-0027 Starting Treatment with Agonist Replacement Therapies (START) Walter Ling, M.D. Jun 06, 2012
CTN NIDA-CTN-0030 A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence Walter Ling, M.D., Roger Weiss, M.D. Jun 22, 2011
CTN NIDA-CTN-0030A3 Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence) Roger Weiss, M.D., Jennifer Sharpe Potter, Ph.D. Aug 22, 2014
CTN NIDA-CTN-0059 The TAPS Tool: Screen and Brief Assessment Tool Validation Study Robert P Schwartz, M.D., Li-Tzy Wu, Psy.D., Jennifer McNeely, M.D. Sep 14, 2017
CTN NIDA-CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment John Rotrosen, M.D. Jan 12, 2018
CTN NIDA-CTN-0075 Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder Li-Tzy Wu, Psy.D., Paolo Mannelli, MD Feb 16, 2023
CTN NIDA-CTN-0093 Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool Gerald Cochran, PhD, T. John Winhusen, Ph.D. Apr 13, 2023